Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

Letter to the Editor   |    
Letters to the Editor
Am J Psychiatry 1998;155:1626t-1626.
View Author and Article Information
St. James, N.Y.

Letters to the Editor

To the Editor: In their clinical case conference, Dr. Hersh and his colleagues describe a 40-day interrupted hospitalization of a 71-year-old man with a severe alcohol history who was admitted to an academic medical center for alcoholism. On day 4 of a withdrawal treatment schedule, the patient developed a delirium that progressively worsened. He was treated with thiamine, chlordiazepoxide, and, eventually, haloperidol for severe agitation. On the 18th day, his score on the Mini-Mental State was 23 of a possible 30, and he was transferred to a rehabilitation facility. He relapsed quickly, however, and was returned to the academic center where conservative treatment with the same medications was continued for an additional 2 weeks. At the time of discharge, he was still not fully recovered.

Had this patient been treated in Denmark or Sweden, he would have been a candidate for ECT R6015511CHDBJBAG. Admittedly, the literature reviewed by Strömgren is sparse. Considering the life-threatening nature of such deliria, as well as the risks of neuroleptic malignant syndrome with the administration of neuroleptics, especially haloperidol, it is reasonable to consider ECT. There is a need for a collaborative study of the merits of ECT in drug-related deliria.

Strömgren LS: ECT in acute delirium and related clinical states. Convuls Ther  1997; 13:10–17


Strömgren LS: ECT in acute delirium and related clinical states. Convuls Ther  1997; 13:10–17

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe

Related Content
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 62.  >
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 9.  >
APA Practice Guidelines > Chapter 0.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 10.  >
APA Practice Guidelines > Chapter 0.  >
Topic Collections
Psychiatric News
APA Guidelines
PubMed Articles